MONOPHARMA

Mono Pharmacare Share Price

 

 

Start SIP in MONOPHARMA

Start SIP

Performance

  • Low
  • ₹11
  • High
  • ₹12
  • 52 Week Low
  • ₹11
  • 52 Week High
  • ₹30
  • Open Price₹12
  • Previous Close₹11
  • Volume16,000
  • 50 DMA₹17.56
  • 100 DMA₹20.43
  • 200 DMA₹24.95

Investment Returns

  • Over 1 Month -28.62%
  • Over 3 Month -47.96%
  • Over 6 Month -54.79%
  • Over 1 Year -61.93%

Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!

Invest Now

Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 6.2
  • PEG Ratio
  • -
  • Market Cap Cr
  • 19
  • P/B Ratio
  • 0.6
  • Average True Range
  • 0.76
  • EPS
  • 1.75
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.85
  • RSI
  • 21.25
  • MFI
  • 11.42

Mono Pharmacare Financials

Mono Pharmacare Technicals

EMA & SMA

Current Price
₹10.85
-0.55 (-4.82%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹14.47
  • 50 Day
  • ₹17.56
  • 100 Day
  • ₹20.43
  • 200 Day
  • ₹24.95

Resistance and Support

11.17 Pivot Speed
  • R3 12.43
  • R2 12.12
  • R1 11.48
  • S1 10.53
  • S2 10.22
  • S3 9.58

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Mono Pharmacare Ltd has an operating revenue of Rs. 356.98 Cr. on a trailing 12-month basis. An annual revenue growth of 38% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 83%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 41 which is a POOR score indicating inconsistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 156 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-29 Quarterly Results & Others To consider other business matters (Revised)
2025-08-26 Others To consider other business matters
2025-05-30 Audited Results & Others (Revised) To consider other business matters.
2025-04-11 Others To consider other business matters (Revised)
2025-02-10 Others To consider other business matters

Mono Pharmacare F&O

Mono Pharmacare Shareholding Pattern

56.72%
34.47%
8.81%

About Mono Pharmacare

  • NSE Symbol
  • MONOPHARMA
  • BSE Symbol
  • Managing Director
  • Mr. Panilam Lakhatariya
  • ISIN
  • INE0OIP01012

Similar Stocks to Mono Pharmacare

Mono Pharmacare FAQs

Mono Pharmacare share price is ₹10 As on 26 January, 2026 | 05:05

The Market Cap of Mono Pharmacare is ₹19.2 Cr As on 26 January, 2026 | 05:05

The P/E ratio of Mono Pharmacare is 6.2 As on 26 January, 2026 | 05:05

The PB ratio of Mono Pharmacare is 0.6 As on 26 January, 2026 | 05:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23